Syringe 2.5ml 22 Gauge

Sirin 2.5 ml 22 g is a veterinary formulation in solution that comes in a 2.5 ml bottle with a nominal weight of 22 g. This product is conceived as a solution for topical use intended for dogs and/or other species indicated in the sheet, designed to facilitate administration, maximize tolerability and guarantee a stable preservation profile. The formulation is designed to allow practical application, with a measurable dosage that allows precise administration according to the animal's body weight. The bottle format favors single and controlled dosage, reducing any waste and simplifying the provision of the treatment even by non-specialist personnel.

The product is designed to be easily manipulated: the solution is fluid, rapidly absorbed by the skin and designed to limit local irritation. The formulation includes excipients that improve its stability and applicability, allowing a homogeneous diffusion on the skin surface without leaving visible sticky residues. The bottle is suitable for storage protected from light and external agents, and the dispenser allows small quantities to be dispensed with precision. Sirin 2.5 ml 22 g is designed to offer a combination of convenience of use, safety and effectiveness when used according to appropriate clinical indications and under the responsibility of the veterinary professional.

The following sheet provides detailed information divided into chapters dedicated to therapeutic indications, composition, contraindications, safety measures for the species, precautions for use, methods of administration, treatment program and target species. Each chapter is comprehensively written to ensure a complete understanding of the usage criteria, practical recommendations and safety considerations necessary for responsible use of the product.

Therapeutic Indications

Sirin 2.5 ml 22 g is indicated for the treatment and/or prevention of skin conditions caused by specific pathogens or parasites, as well as for the therapeutic support of skin conditions requiring local application of a medicinal solution. The therapeutic indications include the treatment of superficial skin infestations by ectoparasites sensitive to the active ingredient present in the formulation, as well as the control of clinical signs associated with dermatitis of parasitic origin when compatible with the activity profile of the active substance. The product can be used as part of an integrated therapeutic strategy that includes accurate veterinary diagnosis, concomitant systemic or topical treatments where necessary and environmental and hygiene measures to limit reinfestation.

In clinical contexts, Sirin 2.5 ml 22 g is indicated to reduce the parasitic load and associated signs such as itching, erythema and local irritation, with the aim of improving the animal's well-being and promoting skin repair. It is indicated for topical use on the coat and skin, in specific anatomical areas suggested by the veterinarian. Use should always be preceded by a complete clinical evaluation, including medical history, objective dermatological examination and, if necessary, complementary tests (e.g. skin scrapings, scotch tests, microscopic examinations) to confirm the nature of the infestation or skin lesion. In the case of integration with other treatments (antibiotics, antifungals, anti-inflammatories), an evaluation of the risk-benefit ratio and therapeutic compatibility is recommended.

The product is intended for targeted treatments in periods of risk or in the presence of documented clinical symptoms; long-term prevention or routine use must be evaluated by the veterinarian based on the local epidemiology, the animal's condition and possible interactions with other products. In case of severe or persistent infestations, the combination with environmental interventions and systemic treatments may be indicated to achieve effective control. Therapeutic efficacy also depends on the correct application and compliance with the methods of administration and the recommended therapeutic program, as well as on the periodic evaluation of the clinical state of the animal.

Composition

Sirin 2.5ml 22g is packaged in a 2.5ml bottle with a nominal weight of 22g. The composition includes the active substance at the appropriate concentration for topical dosage, accompanied by a matrix of excipients that guarantee its stability, solubility and skin biocompatibility. The excipients are selected to minimize the risk of irritation and to promote adequate dispersion of the active ingredient on the skin surface and in the animal's fur. The formulation may include co-solvents, emulsifiers and texturing agents that allow for correct application and rapid drying without visible residue.

The presence of the main solvent and co-excipients is designed to obtain a controlled skin absorption profile, so that the active ingredient is available in the application area with minimal systemic dispersion. The balance between the active ingredient and the excipients has been designed to maximize local efficacy and minimize unwanted systemic pharmacokinetics. The bottle is labeled with the total dosage and instructions for use; the quantity of product contained allows for the delivery of a specific number of applications based on the weight of the animal and the surface to be treated, if the dosage plan indicated by the veterinarian is followed.

For safety and compliance reasons, the formulation is free of unnecessary additives and the excipients used are commonly used in topical veterinary products due to their tolerability and chemical inertness. The chemical-physical stability of the solution is guaranteed by the system of selected excipients, which protect the active ingredient from oxidative degradation and photodegradation, allowing adequate conservation if the product is kept in the indicated conditions. Any known allergies to specific excipients must be communicated to the veterinarian, who will evaluate the suitability of use on an individual basis.

Contraindications

Sirin 2.5 ml 22 g must not be used in the presence of known hypersensitivity to the active ingredient or to any of the excipients listed in the composition. Use in animals with a history of severe skin reactions associated with topical applications of similar products is not recommended, unless otherwise justified by the responsible veterinarian. Use in subjects with extensive, epithelial or infected skin lesions must be evaluated with caution: in such cases, preliminary treatment of the lesions or a different therapeutic approach may be necessary to avoid complications and monitor healing.

Use in debilitated or seriously compromised animals is contraindicated unless the veterinarian has deemed the benefit to outweigh the potential risk. The use on very young puppies, breastfeeding animals or pregnant females must be evaluated on a case-by-case basis: in the absence of adequate and consolidated data on these categories it may be appropriate to avoid use or proceed only after a careful analysis of the risk/benefit ratio by the veterinary surgeon. Avoid accidental applications in ocular or mucosal areas; in case of accidental contact with the eyes, rinse thoroughly with water and, if necessary, consult a veterinarian.

Do not administer simultaneously with other topical products whose compatibility has not been verified: local interactions could modify the efficacy or increase the risk of irritation. Always report any concomitant systemic or topical therapies to the veterinarian, so that it is possible to evaluate any incompatibilities or adjustments to the treatment. In the event of persistent or serious adverse reactions, discontinue use and promptly contact a veterinary professional for management of the case.

Safety of the drug for the species

The safety of use of Sirin 2.5 ml 22 g was evaluated for the declared target species, considering the local tolerability profile and, where available, the pharmacokinetics of the active ingredient after topical application. It is important to underline that, although systemic exposure can be reduced by correct topical administration, cutaneous absorption cannot be completely excluded; therefore, safety must be assessed according to the clinical status of the animal, its age, weight and the presence of concomitant conditions. In the presence of systemic diseases or compromise of vital organs, the veterinarian will need to consider whether the product is appropriate.

To allow a complete evaluation, it is recommended to monitor the animal after the first applications to identify any signs of local intolerance (erythema, edema, accentuated itching) or unusual systemic effects (lethargy, vomiting, behavioral changes). In case of adverse clinical signs, discontinue application and consult your veterinarian to assess the need for supportive treatments. Repeated administration must be carried out respecting the recommended intervals to avoid local or systemic accumulation of the active ingredient and to reduce the risk of side effects.

Safety for non-target species, including companion animals that may come into contact with the treated animal, should be considered: Avoid immediate direct contact between the treated animal and other animals or people until the treated area is dry, to reduce the risk of product transfer. Keep the product out of the reach of children and prevent other animals from accessing the opened package. Any adverse events observed after use must be communicated to the veterinarian to contribute to the continuous evaluation of the risk/benefit ratio of the product.

Precautions

Before using Sirin 2.5 ml 22 g it is important to take precautions to ensure the safety of the animal and the operator. Handle the product wearing disposable gloves to avoid direct contact with the skin and wash your hands thoroughly after application. Remove only the quantity of product necessary for the single application, close the bottle according to the instructions and store the package in a safe place, out of the reach of children and other animals. Avoid applying the product in the presence of large open wounds, burns or severely inflamed areas without veterinary advice.

In the case of animals with a history of hypersensitivity or adverse reactions to topical products, inform your veterinarian: it may be necessary to carry out a preliminary test on a small area of ​​skin or choose a therapeutic alternative. Avoid wetting or washing the treated area in the hours following application, unless otherwise indicated, to allow the active ingredient to settle and provide the expected effect. If signs of intoxication or adverse reactions are observed during the treatment period, discontinue administration and promptly contact a professional for appropriate support measures.

Adopt special precautions when handling animals that have received the treatment: avoid repeatedly touching the treated areas until completely dry and, in case of accidental contact with the operator's skin, wash immediately with soap and water. Do not administer the product to people; If accidental ingestion occurs, contact a doctor and take the product packaging with you. Store the product in the conditions indicated on the label and do not use beyond the recommended period of use after opening, to maintain the effectiveness and safety of the formulation.

Method of administration

Sirin 2.5 ml 22 g should be administered topically following the veterinary instructions regarding the application site, dosage and frequency. Before application, make sure that the skin is dry and that the hair is partially diluted in the intended area to allow direct contact with the skin. Apply the recommended dose starting from the base of the neck or in easily reachable points, avoiding contact with eyes and mucous membranes; distribute the contents in several places if necessary to obtain uniform coverage of the affected area. After application, avoid bathing or prolonged washing of the treated area for the period indicated by the professional, in order to allow the action of the active ingredient.

If the product is accidentally ingested by the animal, contact your veterinarian immediately; do not induce vomiting without specific indications. For animals who are sensitive or skeptical of topical application, your veterinarian may recommend soft restraint and reassurance techniques during the procedure to reduce the animal's stress. If used on multiple animals, use new gloves or wash hands thoroughly between applications to prevent cross-contamination. Application log: note the date, dose and site of application to correctly follow the therapeutic plan and facilitate any subsequent clinical checks.

In situations where it is necessary to combine topical treatment with systemic therapies, follow your veterinarian's recommendations to avoid overlapping effects or unwanted interactions. If you suspect a dose has been missed, do not double the next dose without consulting your veterinarian; follow the instructions provided to recover the dosage. To maximize adherence to treatment, the veterinarian will be able to provide a calendar of applications and practical indications on how to integrate administration into the owner's daily routine.

Treatment program

The treatment program with Sirin 2.5 ml 22 g must be defined by the veterinarian based on the diagnosis, the severity of the condition and the clinical conditions of the animal. For acute infestations, initial treatment may include repeated applications at precise intervals until clinical signs resolve, followed by a maintenance period to prevent recurrences. In the case of preventive control in high-risk contexts, the plan may include periodic applications at regular intervals determined by the action profile of the active ingredient and the analysis of the local epidemiological risk. The veterinarian will establish the overall duration and frequency of applications necessary to ensure effective and sustainable control.

For chronic pathologies or conditions that require long-term control, the therapeutic program may require periodic clinical monitoring, control tests and, if necessary, dosage adjustments. In the presence of recurrent infestations, it is advisable to combine environmental, hygienic and behavioral measures to reduce the sources of re-infestation and improve the effectiveness of the treatment. Combined interventions may include cleaning the environment, treating any environmental outbreaks and training the owner in early recognition of clinical signs.

The evaluation of the effectiveness of the program must be based on periodic clinical checks and, when appropriate, on instrumental or paraclinical tests that document the reduction of the infestation or the resolution of the skin lesions. In the event of an insufficient response or the appearance of adverse effects, the plan may be reviewed by the professional who will evaluate any therapeutic alternatives or dosage adjustments. Compliance with the recommended program is essential to obtain satisfactory therapeutic results and to reduce the risk of relapse or development of resistance to the treated agents.

Target species

The primary target species for Sirin 2.5 ml 22 g are pets for which the product was formulated and tested: the main species of use is the dog. However, use on other species must be carefully evaluated by the veterinarian and only apply when there are clear references of safety and effectiveness for these species. For non-target species or for animals intended for human consumption, the use of the product must be avoided unless otherwise specific professional indications that guarantee food safety and compliance with current regulations.

For each target species it is essential to adjust the dosage according to body weight and the surface to be treated, scrupulously following the instructions provided by the veterinarian. Tolerability and therapeutic response may vary between different species; therefore, use on animals other than those for which it is expressly indicated requires a preliminary clinical evaluation and careful monitoring during treatment. If you are in any doubt about suitability for a specific species, always consult a veterinary healthcare professional for an individual assessment.

The storage, dosage and disposal methods of empty packages must be managed according to good veterinary practices and in compliance with local environmental safety regulations. Keep the product out of reach of children and pets not intended for use and ensure that administration operations are carried out under adequate hygienic conditions to maintain efficacy and safety of use for the target species.